Main Article Content

Dr. Sachin M Darji
Dr. Jigar R. Katwala


Enterococcus, Vancomycin-resistant Enterococci, Prevalence



Enterococci is the part of normal commensals of human intestinal tract which is an important opportunistic pathogens. Arousal of antimicrobial resistance among the enterococci is the main threat to human healthy ecosystem. The present study was carried out to determine the prevalence of antimicrobial resistance among the enterococci i.e. Vancomycin-Resistant Enterococci (VRE) isolated from various clinical samples received from the patients admitted at tertiary care centre at all age group. Early detection, implementing infection control practices to minimize the transmission of infection and antimicrobial stewardship to minimize the arousal of antimicrobial resistance among the enterococci.


 A one year retrospective study was conducted at a tertiary care centre. Various specimens like pus, urine, blood, body fluid etc. were collected from the patients admitted at tertiary care centre of all age. Culture and antimicrobial sensitivity testing was carried out following standard guideline.


During the study period of one year, 950 samples were found to be bacterial culture positive out of which 110 (11.6%) isolates were identified as Enterococcus species. Among 110 enterococcal isolates, 80 (72.7%) isolates were Enterococcus faecalis and 30 (27.3%) were Enterococcus faecium. enterococci more frequently isolated from sample collected from male patient 75 (68.2%) than female patients 35 (31.8%). It was more frequently isolated in patients belongs to age group of 35-40 years (34.5%). Isolates were predominantly resistance to tetracycline (80.9%) followed by ciprofloxacin (70%), Benzyl-penicillin (38.2%), high-level aminoglycosides (36.4%), quinupristin-dalfopristin (5.5%) and vancomycin (3.6%), while linezolide and teicoplanin showed the maximum sensitivity. Our study detected the E.faecium more resistant strain to different antibiotics as compared to E. faecalis.


 Our study reports the prevalence of Enterococci isolates as well as of VRE isolates. To reduce the arousal of VRE prevalence worldwide, appropriate use of antibiotics according to antimicrobial susceptibility testing should be encouraged. Efforts should also be made to reduce the transmission of VRE in the hospital.

Abstract 93 | PDF Downloads 17


1. Hornuss, D., Göpel, S., Walker, S.V. : Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study. from. 20162020,
2. Smout, E., Palanisamy, N. & Valappil, S.P: Prevalence of vancomycin-resistant Enterococci in India between 2000 and 2022: a systematic review and meta-analysis. Antimicrob Resist Infect Control 12. 79:
3. Sachan, S., & Anubhaw, A. (2022: Species prevalence, antimicrobial susceptibility of enterococci isolated from various clinical samples in tertiary care hospital. International Journal of Health Sciences. 6:4507-4514.
4. Klare I, Fleige C, Geringer U, Thürmer A, Bender J, Mutters NT, : Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. J Glob Antimicrob Resist. 2015, 3:128-31. 10.1016/j.jgar.2015.02.007. Epub 2015 Apr 13.
5. Yadav RK, Agarwal L: Enterococcal infections in a tertiary care hospital, North India. Ann Afr Med. 2022, 21:193-197. 10.4103/aam.aam_110_20
6. Collee JG, Fraser AG, Marmion BP, Simmons A: Edinburg. Churchill Livingstone, 1996. pp.:263-74.
7. Clinical and Lboratory Standard Institute CLSI Performance standards for Antimicrobial susceptibility testing M100. (2022). 34th 2022.
8. Cetinkaya Y, Falk P, Mayhall CG: Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000, 13:686-707. 10.1128/CMR.13.4.686
9. Arias CA, Murray BE: The rise of the Enterococcus: Beyond vancomycin resistance. Nat Rev Microbiol. 2012, 10:266-78. 10.1038/nrmicro2761.
10. Agarwal J, Kalyan R, Singh M: High-level aminoglycoside resistance and beta-lactamase production in enterococci at a tertiary care hospital in India. Jpn J Infect Dis. 2009, 62:158-9.
11. Preeti S, Raman M, Nirwan PS, Meeta S, Dahiya SS: Prevalence and antimicrobial susceptibility of Enterococcus Species isolated from different clinical samples in a tertiary care hospital of North India. Natl J Med Res. 2012, 3:389-91.
12. Sood S, Malhotra M, Das BK, Kapil A: Enterococcal infections and antimicrobial resistance. Indian J Med Res. 2008, 128:111-21.
13. Tripathi A, Shukla SK, Singh A, Prasad KN: Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India. Indian J Med Microbiol. 2016, 34:38-45.
14. Chakraborty A, Pal NK, Sarkar S, Gupta MS: Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India. J Nat Sci Biol Med. 2015, 6:394-7.
15. Purohit G, Gaind R, Dawar R, Verma PK, Aggarwal KC, Sardana R,: Characterization of vancomycin resistantenterococci in hospitalized patients and role of gut colonization. J Clin Diagn Res. 201711, 1:5. 10.7860/JCDR/2017/25988.10548
16. Ohri, saniya & singh, kanwardeep & sidhu, shailpreet & oberoi, loveena. (2023). prevalence and antimicrobial resistance in enterococcus species. Asian Journal of Pharmaceutical and Clinical Research. 36-39. 10.22159/ajpcr.2023.v16i6.47283
17. Maraki S, Samonis G, Dimopoulou D, Mantadakis E: Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital. Infect Chemother. 2014, 46:253-256.
18. Sengupta M, Sarkar R, Sarkar S, Sengupta M, Ghosh S, Banerjee P: Vancomycin and Linezolid-Resistant Enterococcus Isolates from a Tertiary Care Center in India. Diagnostics (Basel. 2023, 2:945-10. 10.3390/diagnostics13050945
19. Sivaradjy M, Gunalan A, Priyadarshi K, Madigubba H, Rajshekar D, Sastry AS: Increasing Trend of Vancomycinresistant Enterococci Bacteremia in a Tertiary Care Hospital of South India: A Three-year Prospective Study. Indian J Crit Care Med. 2021, 25:881-885.
20. Faron ML, Ledeboer NA, Buchan BW: Resistance mechanisms, epidemiology, and approaches to screening for vancomycinresistant enterococcus in the health care setting. J Clin Microbiol. 2016, 54:2436-2447. 10.1128/JCM.00211-16
21. Khandelwal N, Panwala T, Patel JS: Prevalence of enterococcus species and its vancomycin resistance pattern in a Tertiary Care Hospital, Surat, Gujarat, India: a growing threat. Int J Recent Sci Res. 2020, 11:3. 10.24327/ijrsr.2020.1107.5480
22. Mathis B, Haïne M, Girard R, Bonnefoy M: Risk factors for vancomycinresistant enterococcus acquisition during a large outbreak in patients aged 65 years and older. BMC Geriatr. 2019, 1186:12877-019. 10.1186/ s12877-019-1398-2
23. Monteserin N, Larson E: Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016, 94:236-241. 10.1016/j.jhin.2016.07.023
24. Moosavian M, Ghadri H, Samli Z: Molecular detection of vanA and vanB genes among vancomycin-resistant enterococci in ICUhospitalized patients in Ahvaz in southwest of Iran. Infect Drug Resist. 2018, 11:2269-2275. 10.2147/IDR.S177886